Table 2.
Self-Report Measures
| Measures | Completers n = 11 |
Intent-to-Treat n = 14 |
|---|---|---|
| PDI-21 | ||
| Baseline | 8.3 (5.8) | 7.4 (5.4) |
| Mid-Treatment | 5.5 (3.9) | 5.2 (3.6) |
| Post-Treatment | 5.2 (4.6) | 4.9 (4.2) |
| 3 Mo. Follow-Up | 4.3 (4.5) | 4.2 (4.1) |
| LSHS-R | ||
| Baseline | 33.6 (12.0) | 30.9 (11.9) |
| Mid-Treatment | 26.9 (13.2) | 25.7 (12.5) |
| Post-Treatment | 26.1 (13.3) | 25.1 (12.5) |
| 3 Mo. Follow-Up | 26.6 (15.2) | 25.5 (14.1) |
| WHODAS-II | ||
| Baseline | 50.8 (18.7) | 50.4 (18.3) |
| Mid-Treatment | 29.0 (20.7) | 28.0 (20.2) |
| Post-Treatment | 28.0 (20.4) | 27.2 (19.8) |
| 3 Mo. Follow-Up | 20.7 (18.1) | 21.4 (18.0) |
| AAQ-II | ||
| Baseline | 36.5 (7.7) | 35.1 (7.5) |
| Mid-Treatment | 23.3 (8.5) | 24.6 (8.9) |
| Post-Treatment | 22.6 (10.7) | 24.1 (10.6) |
| 3 Mo. Follow-Up | 19.1 (7.8) | 21.3 (9.1) |
| BADS | ||
| Baseline | 101.2 (28.6) | 104.0 (26.7) |
| Mid-Treatment | 151.2 (23.8) | 141.4 (27.7) |
| Post-Treatment | 140.5 (35.7) | 139.1 (29.8) |
| 3 Mo. Follow-Up | 152.3 (30.1) | 148.4 (27.6) |
| VLQ | ||
| Baseline | 45.5 (23.4) | 41.3 (22.3) |
| Mid-Treatment | 61.1 (22.4) | 52.7 (26.5) |
| Post-Treatment | 66.5 (20.2) | 57.0 (26.7) |
| 3 Mo. Follow-Up | 69.3 (20.8) | 59.1 (27.9) |
| CAMS-R | ||
| Baseline | 23.3 (8.8) | 23.3 (7.8) |
| Mid-Treatment | 36.5 (5.9) | 33.5 (8.2) |
| Post-Treatment | 36.3 (7.6) | 33.4 (9.1) |
| 3 Mo. Follow-Up | 36.5 (6.6) | 33.6 (8.6) |
Note. BPRS = Brief Psychiatric Rating Scale; PDI-21 = Peters Delusion Inventory-21 Item; LSHS-R = Launay-Slade Hallucinations Scale-Revised; WHODAS-II = World Health Organization Disability Assessment Scale-II; AAQ-II = Acceptance and Action Questionnaire-II; VLQ - Valued Living Questionnaire; BADS = Behavioral Activation in Depression Scale; CAMS-R = Cognitive and Affective Mindfulness Scale-Revised.